Business
Moderna CEO sees virus vaccine interim data in November: Report – Aljazeera.com
US drugmaker’s CEO says Washington could approve vaccine for emergency use in December, Wall Street Journal reports.
Moderna Incs Chief Executive Officer Stephane Bancel expects interim results from its coronavirus vaccine trial in November and that the United States government could approve the drug for emergency use in December, the Wall Street Journal newspaper reported.
Speaking at the newspapers annual Tech Live conference, Bancel also said on Monday that if sufficient interim results from the study are delayed, government permission to use the vaccine may not come until next year.
The first interim ana…
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News13 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business14 hours agoSolid superannuation gains continue to roll in
